CR2Cancer

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Domain, Function and Classification > Gene Ontology > KEGG and Reactome Pathway

> Domain, Function and Classification

[ TOP ]

Domain

PF10294 Lysine methyltransferase

Function

Protein-lysine N-methyltransferase that specifically trimethylates 'Lys-315' of VCP/p97; this modification may decrease VCP ATPase activity.

Classification

Class	Modification	Substrate	Product	PubMed
#	#	#	#	#

> Gene Ontology [ TOP ]
Biological Process	GO:0006479 protein methylation GO:0008213 protein alkylation GO:0018022 peptidyl-lysine methylation GO:0018023 peptidyl-lysine trimethylation GO:0018205 peptidyl-lysine modification GO:0032259 methylation GO:0043414 macromolecule methylation
Molecular Function	GO:0008168 methyltransferase activity GO:0008170 N-methyltransferase activity GO:0008276 protein methyltransferase activity GO:0008757 S-adenosylmethionine-dependent methyltransferase activity GO:0016278 lysine N-methyltransferase activity GO:0016279 protein-lysine N-methyltransferase activity GO:0016741 transferase activity, transferring one-carbon groups
Cellular Component	-

> KEGG and Reactome Pathway [ TOP ]
KEGG	-
Reactome	R-HSA-392499: Metabolism of proteins R-HSA-597592: Post-translational protein modification R-HSA-8876725: Protein methylation

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Mutation landscape in primary tumor tissue from TCGA > Mutation landscape in cancer cell line from CCLE > All mutations from COSMIC database V81 > Variations from text mining

> The Cancer Genome Atlas (TCGA) [ TOP ]

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> Catalogue of Somatic Mutations in Cancer (COSMIC)

[ TOP ]

COSMIC ID	CDS change	AA change	Mutation Type	Anatomical Site
COSM3496145	c.682C>T	p.P228S	Substitution - Missense	Skin
COSM1677967	c.320A>G	p.N107S	Substitution - Missense	Large_intestine
COSM3496144	c.686C>T	p.S229L	Substitution - Missense	Skin
COSM3753974	c.188C>A	p.A63D	Substitution - Missense	Large_intestine
COSM1629309	c.450+4A>C	p.?	Unknown	Liver
COSM4571831	c.552T>C	p.I184I	Substitution - coding silent	Skin
COSM3496145	c.682C>T	p.P228S	Substitution - Missense	Skin
COSM1369939	c.374A>C	p.K125T	Substitution - Missense	Large_intestine
COSM5086782	c.538A>G	p.K180E	Substitution - Missense	Breast
COSM3753974	c.188C>A	p.A63D	Substitution - Missense	Thyroid
COSM4551712	c.537G>A	p.G179G	Substitution - coding silent	Skin
COSM1369938	c.587T>G	p.F196C	Substitution - Missense	Large_intestine
COSM3419832	c.674C>T	p.S225L	Substitution - Missense	Large_intestine
COSM416679	c.105C>T	p.S35S	Substitution - coding silent	Urinary_tract
COSM4148107	c.117T>G	p.G39G	Substitution - coding silent	Thyroid
COSM4188820	c.202C>T	p.R68W	Substitution - Missense	Kidney
COSM4187843	c.478A>G	p.K160E	Substitution - Missense	Kidney
COSM5967044	c.77C>T	p.T26I	Substitution - Missense	Pituitary
COSM1196620	c.562T>G	p.Y188D	Substitution - Missense	Lung
COSM4569436	c.175T>A	p.S59T	Substitution - Missense	Skin
COSM955988	c.408A>G	p.P136P	Substitution - coding silent	Endometrium
COSM5086782	c.538A>G	p.K180E	Substitution - Missense	Breast
COSM1677967	c.320A>G	p.N107S	Substitution - Missense	Large_intestine
COSM469995	c.615A>G	p.K205K	Substitution - coding silent	Kidney
COSM2198254	c.138C>T	p.A46A	Substitution - coding silent	Skin
COSM1726436	c.568G>T	p.E190*	Substitution - Nonsense	Liver
COSM3753974	c.188C>A	p.A63D	Substitution - Missense	Large_intestine
COSM3744347	c.14T>C	p.L5P	Substitution - Missense	Liver
COSM5971162	c.98A>G	p.Y33C	Substitution - Missense	Upper_aerodigestive_tract
COSM5675158	c.187G>T	p.A63S	Substitution - Missense	Soft_tissue

> Text Mining based Variations [ TOP ]
There is no record for VCPKMT.

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Post-translational modification (PTM)

> Post-translational modification (PTM)

[ TOP ]

Filter By:

Uniprot ID	Position	Amino Acid	Description	Upstream Enzyme	Affected By Mutation	Amino Acid Sequence Variant
Q9H867	8	S	Phosphoserine	-	Yes	p.S8L (cancer: LUAD)

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Expression analysis in primary tumor tissue from TCGA > Expression level in cancer cell line from CCLE > Expression level in human normal tissue from HPA > Text mining based expression change

> The Cancer Genome Atlas (TCGA)

[ TOP ]

Differential expression analysis for cancers with more than 10 normal samples

Cancer	Full Name	# N	# T	Median (N)	Median (T)	LogFC	Adj. P	Status
BLCA	Bladder urothelial carcinoma	19	408	2.799	2.896	0.081	0.578	NS
BRCA	Breast invasive carcinoma	112	1100	2.637	2.727	0.1	0.0565	NS
CESC	Cervical and endocervical cancers	3	306	3.136	3.493	NA	NA	NA
COAD	Colon adenocarcinoma	41	459	2.184	2.394	0.093	0.384	NS
ESCA	Esophageal carcinoma	11	185	3.149	3.184	0.111	0.618	NS
GBM	Glioblastoma multiforme	5	166	3.54	2.34	NA	NA	NA
HNSC	Head and Neck squamous cell carcinoma	44	522	2.427	2.802	0.402	4.68e-05	NS
KIRC	Kidney renal clear cell carcinoma	72	534	2.138	2.21	0.139	0.099	NS
KIRP	Kidney renal papillary cell carcinoma	32	291	2.077	2.478	0.292	0.0444	NS
LAML	Acute Myeloid Leukemia	0	173	NA	3.882	NA	NA	NA
LGG	Brain Lower Grade Glioma	0	530	NA	2.221	NA	NA	NA
LIHC	Liver hepatocellular carcinoma	50	373	1.784	1.774	-0.042	0.655	NS
LUAD	Lung adenocarcinoma	59	517	2.489	2.776	0.368	1.19e-06	NS
LUSC	Lung squamous cell carcinoma	51	501	2.255	3.042	0.764	5.15e-18	Over
OV	Ovarian serous cystadenocarcinoma	0	307	NA	2.996	NA	NA	NA
PAAD	Pancreatic adenocarcinoma	4	179	2.668	2.828	NA	NA	NA
PCPG	Pheochromocytoma and Paraganglioma	3	184	2.787	2.481	NA	NA	NA
PRAD	Prostate adenocarcinoma	52	498	2.347	2.469	0.041	0.552	NS
READ	Rectum adenocarcinoma	10	167	2.479	2.213	-0.326	0.192	NS
SARC	Sarcoma	2	263	2.54	2.869	NA	NA	NA
SKCM	Skin Cutaneous Melanoma	1	472	3.04	2.329	NA	NA	NA
STAD	Stomach adenocarcinoma	35	415	2.486	2.723	0.203	0.0624	NS
TGCT	Testicular Germ Cell Tumors	0	156	NA	3.111	NA	NA	NA
THCA	Thyroid carcinoma	59	509	2.683	2.775	0.048	0.395	NS
THYM	Thymoma	2	120	3.673	3.569	NA	NA	NA
UCEC	Uterine Corpus Endometrial Carcinoma	35	546	2.878	2.932	-0.03	0.841	NS

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA)

[ TOP ]

Tissue	Expression Level (TPM)
Adipose tissue	2.1
Adrenal gland	3.4
Appendix	5
Bone marrow	3.3
Breast	2.5
Cerebral cortex	4.7
Cervix, uterine	2.9
Colon	2
Duodenum	1.9
Endometrium	5.3
Epididymis	3.4
Esophagus	4.1
Fallopian tube	3.1
Gallbladder	3.9
Heart muscle	0.9
Kidney	2.2
Liver	1.2
Lung	2.2
Lymph node	5.1
Ovary	1.2
Pancreas	0.2
Parathyroid gland	3.2
Placenta	2.4
Prostate	2.6
Rectum	2
Salivary gland	0.6
Seminal vesicle	2.4
Skeletal muscle	0.6
Skin	3.5
Small intestine	2.4
Smooth muscle	2.3
Spleen	3
Stomach	2.3
Testis	3.6
Thyroid gland	4.3
Tonsil	4.5
Urinary bladder	3.4

> Text Mining based Expression [ TOP ]
There is no record.

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Somatic copy number alteration in primary tomur tissue

> The Cancer Genome Atlas (TCGA) [ TOP ]
There is no record.

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Methylation level in the promoter region of CR

> Methylation level in the promoter region of CR

[ TOP ]

Correlation between expression and methylation as well as differential methylation analysis.

Cancer	Full Name	R	P	# N	# T	Delta beta (T vs N)	P value (T vs N)	Status
BLCA	Bladder urothelial carcinoma	-0.252	1.5e-07	17	408	-0.001	0.834	NS/NA
BRCA	Breast invasive carcinoma	-0.184	5.41e-08	83	785	-0.25	2.08e-65	Decreased
CESC	Cervical and endocervical cancers	-0.211	0.000193	3	306	NA	NA	NS/NA
COAD	Colon adenocarcinoma	-0.214	0.000135	19	297	0.001	0.000347	NS/NA
ESCA	Esophageal carcinoma	-0.339	1.59e-06	9	185	NA	NA	NS/NA
GBM	Glioblastoma multiforme	-0.36	0.00341	1	64	NA	NA	NS/NA
HNSC	Head and Neck squamous cell carcinoma	-0.137	0.00143	20	522	0.01	0.653	NS/NA
KIRC	Kidney renal clear cell carcinoma	-0.204	0.000149	24	319	-0.166	6.38e-09	NS/NA
KIRP	Kidney renal papillary cell carcinoma	-0.043	0.457	23	275	-0.017	1.75e-05	NS/NA
LAML	Acute Myeloid Leukemia	-0.157	0.0406	0	170	NA	NA	NS/NA
LGG	Brain Lower Grade Glioma	-0.266	5.74e-10	0	530	NA	NA	NS/NA
LIHC	Liver hepatocellular carcinoma	-0.271	2.29e-08	41	373	0.016	0.00885	NS/NA
LUAD	Lung adenocarcinoma	-0.163	0.000348	21	456	-0.014	0.00168	NS/NA
LUSC	Lung squamous cell carcinoma	-0.102	0.0465	8	370	NA	NA	NS/NA
OV	Ovarian serous cystadenocarcinoma	-0.783	0.0172	0	9	NA	NA	NS/NA
PAAD	Pancreatic adenocarcinoma	-0.099	0.183	4	179	NA	NA	NS/NA
PCPG	Pheochromocytoma and Paraganglioma	-0.182	0.0128	3	184	NA	NA	NS/NA
PRAD	Prostate adenocarcinoma	-0.295	4.72e-12	35	498	-0.035	5.72e-11	NS/NA
READ	Rectum adenocarcinoma	-0.156	0.119	2	99	NA	NA	NS/NA
SARC	Sarcoma	-0.347	8.95e-09	0	263	NA	NA	NS/NA
SKCM	Skin Cutaneous Melanoma	-0.194	2.29e-05	1	471	NA	NA	NS/NA
STAD	Stomach adenocarcinoma	-0.247	1.53e-06	0	372	NA	NA	NS/NA
TGCT	Testicular Germ Cell Tumors	-0.236	0.00314	0	156	NA	NA	NS/NA
THCA	Thyroid carcinoma	-0.286	6.45e-12	50	509	-0.008	0.551	NS/NA
THYM	Thymoma	-0.157	0.0841	2	120	NA	NA	NS/NA
UCEC	Uterine Corpus Endometrial Carcinoma	-0.328	4.99e-13	34	431	0.006	0.852	NS/NA

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Primary tumor tissue from TCGA > Normal tumor tissue from HPA

>The Cancer Genome Atlas (TCGA) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA)

[ TOP ]

Tissue	Level	Level Name
Adrenal gland	2	Medium
Appendix	2	Medium
Bone marrow	1	Low
Breast	2	Medium
Bronchus	2	Medium
Caudate	1	Low
Cerebellum	2	Medium
Cerebral cortex	2	Medium
Cervix, uterine	2	Medium
Colon	2	Medium
Duodenum	2	Medium
Endometrium	2	Medium
Epididymis	2	Medium
Esophagus	2	Medium
Fallopian tube	2	Medium
Gallbladder	2	Medium
Heart muscle	2	Medium
Hippocampus	1	Low
Kidney	2	Medium
Liver	2	Medium
Lung	2	Medium
Lymph node	1	Low
Nasopharynx	1	Low
Oral mucosa	2	Medium
Ovary	2	Medium
Pancreas	2	Medium
Parathyroid gland	2	Medium
Placenta	2	Medium
Prostate	2	Medium
Rectum	2	Medium
Salivary gland	2	Medium
Seminal vesicle	2	Medium
Skeletal muscle	1	Low
Skin	3	High
Small intestine	2	Medium
Smooth muscle	2	Medium
Soft tissue	3	High
Spleen	1	Low
Stomach	2	Medium
Testis	2	Medium
Thyroid gland	2	Medium
Tonsil	2	Medium
Urinary bladder	2	Medium
Vagina	2	Medium

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Association between expresson and subtype > Overall survival analysis based on expression > Association between expresson and stage > Association between expresson and grade

> Subtype

[ TOP ]

Association between expresson and subtype.

Cancer	Full Name	# Patients	P Value (Kruskal-Wallis)	Association	Source
BLCA	Bladder urothelial carcinoma	128	0.696	NS	24476821
BRCA	Breast invasive carcinoma	521	0.823	NS	23000897
COAD	Colon adenocarcinoma	149	0.00663	Significant	22810696
GBM	Glioblastoma multiforme	157	0.597	NS	26824661
HNSC	Head and Neck squamous cell carcinoma	279	2.34e-05	Significant	25631445
KIRP	Kidney renal papillary cell carcinoma	161	5.25e-07	Significant	26536169
LGG	Brain Lower Grade Glioma	513	1.49e-07	Significant	26824661
LUAD	Lung adenocarcinoma	230	0.0309	Significant	25079552
LUSC	Lung squamous cell carcinoma	178	0.00058	Significant	22960745
OV	Ovarian serous cystadenocarcinoma	287	0.000528	Significant	21720365
PRAD	Prostate adenocarcinoma	333	0.61	NS	26544944
READ	Rectum adenocarcinoma	67	0.0176	Significant	22810696
SKCM	Skin Cutaneous Melanoma	315	0.322	NS	26091043
STAD	Stomach adenocarcinoma	277	0.000138	Significant	25079317
THCA	Thyroid carcinoma	391	0.0901	NS	25417114
UCEC	Uterine Corpus Endometrial Carcinoma	232	0.434	NS	23636398

> Overall survival

[ TOP ]

Overall survival analysis based on expression.

Cancer	Full Name	# Patients	Hazard Ratio	P Value (Log Rank Test)	Association
BLCA	Bladder urothelial carcinoma	405	0.906	0.635	NS
BRCA	Breast invasive carcinoma	1079	1.166	0.504	NS
CESC	Cervical and endocervical cancers	291	0.782	0.51	NS
COAD	Colon adenocarcinoma	439	1.109	0.711	NS
ESCA	Esophageal carcinoma	184	1.512	0.205	NS
GBM	Glioblastoma multiforme	158	0.944	0.812	NS
HNSC	Head and Neck squamous cell carcinoma	518	0.783	0.195	NS
KIRC	Kidney renal clear cell carcinoma	531	1.733	0.00783	Shorter
KIRP	Kidney renal papillary cell carcinoma	287	0.882	0.796	NS
LAML	Acute Myeloid Leukemia	149	0.741	0.303	NS
LGG	Brain Lower Grade Glioma	511	1.075	0.759	NS
LIHC	Liver hepatocellular carcinoma	365	0.737	0.207	NS
LUAD	Lung adenocarcinoma	502	0.785	0.253	NS
LUSC	Lung squamous cell carcinoma	494	0.492	0.000354	Longer
OV	Ovarian serous cystadenocarcinoma	303	1.058	0.801	NS
PAAD	Pancreatic adenocarcinoma	177	0.548	0.0685	NS
PCPG	Pheochromocytoma and Paraganglioma	179	579591168.8	0.323	NS
PRAD	Prostate adenocarcinoma	497	684830496.836	0.0351	Shorter
READ	Rectum adenocarcinoma	159	1.026	0.962	NS
SARC	Sarcoma	259	1.817	0.0355	Shorter
SKCM	Skin Cutaneous Melanoma	459	0.59	0.00849	Longer
STAD	Stomach adenocarcinoma	388	0.829	0.41	NS
TGCT	Testicular Germ Cell Tumors	134	0	0.157	NS
THCA	Thyroid carcinoma	500	1.737	0.409	NS
THYM	Thymoma	119	0.211	0.148	NS
UCEC	Uterine Corpus Endometrial Carcinoma	543	1.063	0.837	NS

> Stage

[ TOP ]

Association between expresson and stage.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
BLCA	Bladder urothelial carcinoma	406	-0.094	0.0589	NS
BRCA	Breast invasive carcinoma	1071	0	0.998	NS
CESC	Cervical and endocervical cancers	167	-0.049	0.529	NS
COAD	Colon adenocarcinoma	445	-0.011	0.811	NS
ESCA	Esophageal carcinoma	162	-0.099	0.209	NS
HNSC	Head and Neck squamous cell carcinoma	448	0.027	0.575	NS
KIRC	Kidney renal clear cell carcinoma	531	0.061	0.16	NS
KIRP	Kidney renal papillary cell carcinoma	260	-0.241	8.6e-05	Lower
LIHC	Liver hepatocellular carcinoma	347	-0.03	0.577	NS
LUAD	Lung adenocarcinoma	507	-0.146	0.000969	Lower
LUSC	Lung squamous cell carcinoma	497	0.049	0.277	NS
OV	Ovarian serous cystadenocarcinoma	302	0.012	0.838	NS
PAAD	Pancreatic adenocarcinoma	176	-0.009	0.908	NS
READ	Rectum adenocarcinoma	156	0.01	0.902	NS
SKCM	Skin Cutaneous Melanoma	410	-0.011	0.817	NS
STAD	Stomach adenocarcinoma	392	0.052	0.306	NS
TGCT	Testicular Germ Cell Tumors	81	-0.329	0.00271	Lower
THCA	Thyroid carcinoma	499	0.037	0.405	NS
UCEC	Uterine Corpus Endometrial Carcinoma	501	0.057	0.205	NS

> Grade

[ TOP ]

Association between expresson and grade.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
CESC	Cervical and endocervical cancers	272	-0.065	0.287	NS
HNSC	Head and Neck squamous cell carcinoma	498	-0.031	0.497	NS
KIRC	Kidney renal clear cell carcinoma	525	-0.039	0.371	NS
LGG	Brain Lower Grade Glioma	514	-0.059	0.183	NS
LIHC	Liver hepatocellular carcinoma	366	-0.037	0.482	NS
OV	Ovarian serous cystadenocarcinoma	296	0.012	0.833	NS
PAAD	Pancreatic adenocarcinoma	176	-0.113	0.134	NS
STAD	Stomach adenocarcinoma	406	-0.063	0.203	NS
UCEC	Uterine Corpus Endometrial Carcinoma	534	0.093	0.0315	Higher

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Targets inferred by reverse engineering method > Targets identified by ChIP-seq data

> Targets inferred by reverse engineering method [ TOP ]

> Targets identified by ChIP-seq data [ TOP ]

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Drugs from DrugBank database

> Drugs from DrugBank database [ TOP ]
There is no record for VCPKMT.

Summary
Symbol	VCPKMT
Name	valosin containing protein lysine methyltransferase
Aliases	VCP-KMT; C14orf138; METTL21D; chromosome 14 open reading frame 138; methyltransferase like 21D; VCP lysine m ......
Location	14q21.3
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Protein-Protein Interaction Network > miRNA Regulatory Relationship > Interactions from Text Mining

> Protein-Protein Interaction Network [ TOP ]

> miRNA Regulatory Relationship [ TOP ]
There is no record for VCPKMT.

> Interactions from Text Mining [ TOP ]
There is no record for VCPKMT.